Legislative mandate exists to address unfair prices in pharma sector, says EU enforcer

Despite the difficulty of pursuing excessive-pricing cases in the pharmaceuticals sector, the European Commission has a legislative mandate to go after such concerns, a director at the EU enforcer has said.

Get unlimited access to all Global Competition Review content